> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Drug Quality Experiential Learning Site Visit Program
- URL: https://www.fdaweb.com/drug-quality-experiential-learning-site-visit-program/
- Published: 2019-10-17T12:00:00.000Z
- Updated: 2026-09-15T01:57:32.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5145273

*Federal Register* notice: FDA has announced it is accepting invitations to participate in the Fiscal Year 2020 CDER Office of Pharmaceutical Quality (OPQ) Staff Experiential Learning Site Visit Program. Pharmaceutical companies interested in participating in this program should submit a site visit proposal to OPQ by 11/17\. The program is designed to offer experiential and firsthand learning opportunities that will provide OPQ staff with a better understanding of the pharmaceutical industry and its operations, as well as the challenges that impact a drug’s developmental program and commercial lifecycle. To view the notice, click [here](https://s3.amazonaws.com/public-inspection.federalregister.gov/2019-22767.pdf?ref=fdaweb.com).